miRNA-191 promotes proliferation, migration and invasion of prostate cancer by targeting PLCD1

doi:10.12047/j.cjap.6031.2020.133

Abstract

Abstract: Objective: To investigate the effects of miRNA-191 on the proliferation, migration and invasion of prostate cancer, and to explore its mechanism. Methods: The expression levels of miRNA-191 in four human prostate cancer cell lines (PC-3, DU-145, LNCa P, 22RU1) and human normal prostate cell line RWPE-2 were detected, and prostate cancer cell line PC-3 was selected as the experimental object. PC-3 cells were divided into three groups: blank control group (no transfection), miRNA-191 NC group (PC-3 cells transfected with Inhibitor NC) and miRNA-191 Inhibitor group (PC-3 cells transfected with miRNA-191 Inhibitor), and each group was provided with three multiple pores. The expression levels of miRNA-191 and PLCD1 were detected by RT-PCR. The cell proliferation was detected by CCK8 assay. Scratch test and invasive test were used to detect cell migration and invasive ability. Through Targetscan target gene prediction website, PLCD1 was screened as the target protein of miRNA-191, and verified by double luciferase target experiment.Western blot assay was used to detect the expression of PLCD1 in cells of each group. Results: Compared with RWPE-2 cells, the expression level of miRNA-191 in human prostate cancer cells was significantly higher (P ＜0.05), and the expression level of miRNA191 in PC-3 was significantly higher than that in other three cell lines (P＜0.05). After inhibiting the expression of miRNA-191, the expression levels of PLCD1 was significantly higher while PC-3 cells' proliferation ability was inhibited, and their migration and invasion ability were significantly lower than those of blank control group and miRNA-191 NC group (P＜ 0.05). The results of double luciferase reporter gene assay showed that PLCD1 gene was a target gene of miRNA-191. Conclusion: miRNA-191 promote the proliferation, migration and invasion of prostate cancer PC-3 cells by targeting PLCD1.

Key words: prostate cancer, miRNA-191, PLCD1, proliferation, migration, invasion

CLC Number:

R737.25

NIE Yong-li, TANG Shi-min, PENG Fang, XU Tao, MAO Yong-rong. miRNA-191 promotes proliferation, migration and invasion of prostate cancer by targeting PLCD1[J]. CJAP, 2020, 36(6): 637-641.

References

[1] Jamal A, Narcis H, Visnja VH, et al. TGF-BETA in the natural history of prostate cancer[J]. Acta Clin Croat, 2019, 58(1): 128-138.
[2] 张栋, 苏瑞, 程跃, 等. 高强度聚焦超声治疗前列腺癌的临床进展[J]. 重庆医科大学学报, 2019, 44(2): 7-10.
[3] Xue J, Yang M, Hua LH, et al. MiRNA-191 functions as an oncogene in primary glioblastoma by directly targeting NDST1[J]. Eur Rev Med Pharmacol Sci, 2019, 23(14): 6242-6249.
[4] Li H, Zhou ZQ, Yang ZR, et al. MicroRNA-191 acts as a tumor promoter by modulating the TET1-p53 pathway in intrahepatic cholangiocarcinoma[J]. Hepatology, 2017, 66(1): 136-151.
[5] Song Z, Ren H, Gao S, et al. The clinical significance and regulation mechanism of hypoxia-inducible factor-1 and miR-191 expression in pancreatic cancer[J]. Tumour Biol, 2014, 35(11): 11319-11328.
[6] Goto T, Fujiya M, Konishi H, et al. An elevated expression of serum exosomal microRNA-191, -21, -451a of pancreatic neoplasm is considered to be efficient diagnostic marker[J]. BMC Cancer, 2018, 18(1): 116-127.
[7] 宋广玉, 孙玲玲. microRNA-191在弥漫大B细胞淋巴瘤患者中的表达及其作用机制研究[J]. 解剖学研究, 2018, 40(1): 40-43.
[8] He X, Meng F, Yu ZJ, et al. PLCD1 suppressed cellular proliferation, invasion, and migration via inhibition of Wnt/β-catenin signaling pathway in esophageal squamous cell carcinoma[J]. Dig Dis Sci, 2020. DOI: 10.1007/s10620-020-06218-1.
[9] Xiang Q, He XQ, Mu JH, et al. The phosphoinositide hydrolase phospholipase C delta1 inhibits epithelial-mesenchymal transition and is silenced in colorectal cancer[J]. J Cell Physiol, 2019, 234(8): 13906-13916.
[10] Cai T, Santi R, Tamanini, et al. Current knowledge of the potential links between inflammation and prostate cancer[J]. Int J Mol Sci, 2019, 20(15): 3383-3397.
[11] Wu Y, Hu L, Qin Z, et al. MicroRNA302a upregulation mediates chemoresistance in prostate cancer cells[J]. Mol Med Rep, 2019, 19(5): 4433-4440.
[12] Xu W, Ji J, Xu Y, et al. MicroRNA-191, by promoting the EMT and increasing CSC-like properties, is involved in neoplastic and metastatic properties of transformed human bronchial epithelial cells[J]. Mol Carcinog, 2015, 54(S1): E148-E161.
[13] Kang PC, Leng KM, Liu YP, et al. miR-191 inhibition induces apoptosis through reactivating secreted frizzled-related protein-1 in cholangiocarcinoma[J]. Cell Physiol Biochem, 2018, 49(5): 1933-1942.
[14] Zhang XF, Li KK, Gao L, et al. miR-191 promotes tumorigenesis of human colorectal cancer through targeting C/EBPβ[J]. Oncotarget, 2015, 6(6): 4144-4158.
[15] Takuma G, Mikihiro F, Hiroaki K, et al. An elevated expression of serum exosomal microRNA-191, -21, -451a of pancreatic neoplasm is considered to be efficient diagnostic marker[J]. BMC Cancer, 2018, 18(1): 116-127.
[16] Liu YM, Liu W, Jia JS, et al. Abnormalities of hair structure and skin histology derived from CRISPR/Cas9-based knockout of phospholipase C-delta 1 in mice[J]. J Transl Med, 2018, 16(1): 141-153.
[17] Clotaire DZJ, Wang YF, Huang WW, et al. MiR-26b acts as a tumor suppressor microRNA in prostate cancer[J]. Prog Biochem Biophys, 2017, 44(6): 504-514.
[18] 夏迎晨, 甄杰, 叶飞, 等. MicroRNA-145通过丝裂原活化蛋白激酶和磷脂酰肌醇3激酶/蛋白质丝氨酸苏氨酸激酶通路调控肺癌A549细胞系转移及侵袭[J]. 解剖学报, 2018, 49(5): 73-78.
[19] 孙国栋, 郑名华, 田南南, 等. miRNA-191对人乳腺癌细胞增殖、侵袭的影响[J]. 广东药科大学学报, 2015, 31(1): 99-103.
[20] 胡丹, 姜政. 磷脂酶C δ1 (PLCD1) 抑制CAPAN-1和BXPC-3胰腺癌细胞增殖和侵袭迁移[J]. 细胞与分子免疫学杂志, 2016, 32(6): 739-745.
[21] Mu HX, Wang N, Zhao LJ, et al. Methylation of PLCD1 and adenovirus-mediated PLCD1 overexpression elicits a gene therapy effect on human breast cancer[J]. Exp Cell Res, 2015, 332(2): 179-189.